Chapter 1. Introduction


1.1. Report description and scope

1.2. Research scope

1.3. Research methodology


1.3.1. Market research process

1.3.2. Market research methodology

Chapter 2. Executive Summary


2.1. Global antithrombin market, 2016 2022 (USD Million)

2.2. Global antithrombin market : Snapshot

Chapter 3. Antithrombin Market Dynamics


3.1. Introduction

3.2. Market drivers


3.2.1. Global antithrombin market drivers: Impact analysis

3.2.2. Increasing use of antithrombin as a combination therapy

3.2.3. Significant adoption of antithrombin therapies

3.3. Market restraints


3.3.1. Global antithrombin market restraints: Impact analysis

3.3.2. Usage of substitute and conventional anticoagulants

3.3.3. Pricing Pressure

3.4. Opportunities


3.4.1. Rising chronic diseases

3.5. Porters five forces analysis


3.5.1. Bargaining power of suppliers

3.5.2. Bargaining power of buyers

3.5.3. Threat from new entrants

3.5.4. Threat from new substitutes

3.5.5. Degree of competition

3.6. Market attractiveness analysis


3.6.1. Market attractiveness analysis, by source segment

3.6.2. Market attractiveness analysis, by application segment

3.6.3. Market attractiveness analysis, by dosage form segment

3.6.4. Market attractiveness analysis, by regional segment

Chapter 4. Global Antithrombin Market Competitive Landscape


4.1. Company Market Share Analysis


4.1.1. Global antithrombin market: company market share, 2016

4.2. Strategic Development


4.2.1. Acquisitions Mergers

4.2.2. New Therapy Launch

4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures

4.2.4. Research and Development, Therapy and Regional Expansion

4.3. Price Trend Analysis

4.4. Technology Portfolio

Chapter 5. Global Antithrombin Market Source Segment Analysis


5.1. Global antithrombin market: Source type overview


5.1.1. Global antithrombin market revenue share, by source, 2016 and 2022

5.2. Human


5.2.1. Global human market , 2016 2022(USD Million)

5.3. Goat milk


5.3.1. Global goat milk market , 2016 2022(USD Million)

Chapter 6. Global Antithrombin Market Application Segment Analysis


6.1. Global antithrombin market: Application overview


6.1.1. Global antithrombin market revenue share, by application, 2016 2022

6.2. Diagnostics


6.2.1. Global antithrombin market for diagnostics, 2016 2022 (USD Million)

6.3. Therapeutics


6.3.1. Global antithrombin market for therapeutics, 2016 2022(USD Million)

6.4. Research


6.4.1. Global antithrombin market for research, 2016 2022 (USD Million)

Chapter 7. Global Antithrombin Market Dosage form Segment Analysis


7.1. Global antithrombin market: Dosage form overview


7.1.1. Global antithrombin market revenue share, by dosage form, 2016 and 2022

7.2. Liquid


7.2.1. Global antithrombin market for liquid, 2016 2022 (USD Million)

7.3. Lyophilized


7.3.1. Global antithrombin market for lyophilized, 2016 2022(USD Million)

Chapter 8. Global Antithrombin Market Regional Segment Analysis


8.1. Global antithrombin market: Regional overview


8.1.1. Global antithrombin market revenue share, by region, 2016 and 2022

8.2. North America


8.2.1. North America antithrombin market revenue, by source, 2014 2022 (USD Million)

8.2.2. North America antithrombin market revenue, by application, 2014 2022 (USD Million)

8.2.3. North America antithrombin market revenue, by dosage form, 2014 2022 (USD Million)

8.2.4. U.S.


8.2.4.1. U.S. antithrombin market revenue, by source, 2014 2022(USD Million)

8.2.4.2. U.S. antithrombin market revenue, by application, 2014 2022(USD Million)

8.2.4.3. U.S. antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.2.5. Canada


8.2.5.1. Canada antithrombin market revenue, by source, 2014 2022(USD Million)

8.2.5.2. Canada antithrombin market revenue, by application, 2014 2022(USD Million)

8.2.5.3. Canada antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.2.6. Rest of North America


8.2.6.1. Rest of North of America antithrombin market revenue, by source, 2014 2022(USD Million)

8.2.6.2. Rest of North of America antithrombin market revenue, by application, 2014 2022(USD Million)

8.2.6.3. Rest of North of America antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.3. Europe


8.3.1. Europe antithrombin market revenue, by source, 2014 2022(USD Million)

8.3.2. Europe antithrombin market revenue, by application, 2014 2022(USD Million)

8.3.3. Europe antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.3.4. Germany


8.3.4.1. Germany antithrombin market revenue, by source, 2014 2022(USD Million)

8.3.4.2. Germany antithrombin market revenue, by application, 2014 2022(USD Million)

8.3.4.3. Germany antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.3.5. UK


8.3.5.1. UK antithrombin market revenue, by source, 2014 2022(USD Million)

8.3.5.2. UK antithrombin market revenue, by application, 2014 2022(USD Million)

8.3.5.3. UK antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.3.6. France


8.3.6.1. France antithrombin market revenue, by source, 2014 2022(USD Million)

8.3.6.2. France antithrombin market revenue, by application, 2014 2022(USD Million)

8.3.6.3. France antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.3.7. Italy


8.3.7.1. Italy antithrombin market revenue, by source, 2014 2022(USD Million)

8.3.7.2. Italy antithrombin market revenue, by application, 2014 2022(USD Million)

8.3.7.3. Italy antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.3.8. Spain


8.3.8.1. Spain antithrombin market revenue, by source, 2014 2022(USD Million)

8.3.8.2. Spain antithrombin market revenue, by application, 2014 2022(USD Million)

8.3.8.3. Spain antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.3.9. Russia


8.3.9.1. Russia antithrombin market revenue, by source, 2014 2022(USD Million)

8.3.9.2. Russia antithrombin market revenue, by application, 2014 2022(USD Million)

8.3.9.3. Russia antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.4. Asia Pacific


8.4.1. Asia Pacific antithrombin market revenue, by source, 2014 2022, (USD Million)

8.4.2. Asia Pacific antithrombin market revenue, by application, 2014 2022, (USD Million)

8.4.3. Asia Pacific antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.4.4. China


8.4.4.1. China antithrombin market revenue, by source, 2014 2022(USD Million)

8.4.4.2. China antithrombin market revenue, by application, 2014 2022(USD Million)

8.4.4.3. China antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.4.5. Japan


8.4.5.1. Japan antithrombin market revenue, by source, 2014 2022(USD Million)

8.4.5.2. Japan antithrombin market revenue, by application, 2014 2022(USD Million)

8.4.5.3. Japan antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.4.6. India


8.4.6.1. India antithrombin market revenue, by source, 2014 2022(USD Million)

8.4.6.2. India antithrombin market revenue, by application, 2014 2022(USD Million)

8.4.6.3. India antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.4.7. Australia


8.4.7.1. Australia antithrombin market revenue, by source, 2014 2022(USD Million)

8.4.7.2. Australia antithrombin market revenue, by application, 2014 2022(USD Million)

8.4.7.3. Australia antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.4.8. Rest of Asia Pacific


8.4.8.1. Rest of Asia Pacific antithrombin market revenue, by source, 2014 2022(USD Million)

8.4.8.2. Rest of Asia Pacific antithrombin market revenue, by application, 2014 2022(USD Million)

8.4.8.3. Rest of Asia Pacific antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.5. Latin America


8.5.1. Latin America antithrombin market revenue, by source, 2014 2022(USD Million)

8.5.2. Latin America antithrombin market revenue, by application, 2014 2022(USD Million)

8.5.3. Latin America antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.5.4. Brazil


8.5.4.1. Brazil antithrombin market revenue, by source, 2014 2022(USD Million)

8.5.4.2. Brazil antithrombin market revenue, by application, 2014 2022 (USD Million)

8.5.4.3. Brazil antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.5.5. Mexico


8.5.5.1. Mexico antithrombin market revenue, by source, 2014 2022(USD Million)

8.5.5.2. Mexico antithrombin market revenue, by application, 2014 2022 (USD Million)

8.5.5.3. Mexico antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.5.6. Rest of Latin America


8.5.6.1. Rest of Latin America antithrombin market revenue, by source, 2014 2022(USD Million)

8.5.6.2. Rest of Latin America antithrombin market revenue, by application, 2014 2022 (USD Million)

8.5.6.3. Rest of Latin America antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.6. Middle East and Africa


8.6.1. Middle East and Africa antithrombin market revenue, by source, 2014 2022 (USD Million)

8.6.2. Middle East and Africa antithrombin market revenue, by application, 2014 2022 (USD Million)

8.6.3. Middle East and Africa antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.6.4. Saudi Arabia


8.6.4.1. Saudi Arabia antithrombin market revenue, by source, 2014 2022(USD Million)

8.6.4.2. Saudi Arabia antithrombin market revenue, by application, 2014 2022 (USD Million)

8.6.4.3. Saudi Arabia antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.6.5. UAE


8.6.5.1. UAE antithrombin market revenue, by source, 2014 2022(USD Million)

8.6.5.2. UAE antithrombin market revenue, by application, 2014 2022 (USD Million)

8.6.5.3. UAE antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.6.6. South Africa


8.6.6.1. South Africa antithrombin market revenue, by source, 2014 2022(USD Million)

8.6.6.2. South Africa antithrombin market revenue, by application, 2014 2022 (USD Million)

8.6.6.3. South Africa antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.6.7. Qatar


8.6.7.1. Qatar antithrombin market revenue, by source, 2014 2022(USD Million)

8.6.7.2. Qatar antithrombin market revenue, by application, 2014 2022 (USD Million)

8.6.7.3. Qatar antithrombin market revenue, by dosage form, 2014 2022(USD Million)

8.6.8. Rest of Middle East and Africa


8.6.8.1. Rest of Middle East and Africa antithrombin market revenue, by source, 2014 2022(USD Million)

8.6.8.2. Rest of Middle East and Africa antithrombin market revenue, by application, 2014 2022 (USD Million)

8.6.8.3. Rest of Middle East and Africa antithrombin market revenue, by dosage form, 2014 2022(USD Million)


Chapter 9. Company Profile


9.1. Grifols


9.1.1. Overview

9.1.2. Financials

9.1.3. Therapy portfolio

9.1.4. Business strategy

9.1.5. Recent developments

9.2. rEVO Biologics, Inc.


9.2.1. Overview

9.2.2. Financials

9.2.3. Therapy portfolio

9.2.4. Business strategy

9.2.5. Recent developments

9.3. Shire


9.3.1. Overview

9.3.2. Financials

9.3.3. Therapy portfolio

9.3.4. Business strategy

9.3.5. Recent developments

9.4. Kedrion S.p.A


9.4.1. Overview

9.4.2. Financials

9.4.3. Therapy portfolio

9.4.4. Business strategy

9.4.5. Recent developments

9.5. CSL Limited


9.5.1. Overview

9.5.2. Financials

9.5.3. Therapy portfolio

9.5.4. Business strategy

9.5.5. Recent developments

9.6. Scripps Laboratories Inc.


9.6.1. Overview

9.6.2. Financials

9.6.3. Therapy portfolio

9.6.4. Business strategy

9.6.5. Recent developments

9.7. Lee BioSolutions


9.7.1. Overview

9.7.2. Financials

9.7.3. Therapy portfolio

9.7.4. Business strategy

9.7.5. Recent developments